Showing results (401-410 of 4,499) with videos related to
Sort By:
Pageof 450
Advances in Therapy|September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French RegistryMarkqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.Advances in Therapy|September 14, 2024
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficileAntoine Boustany, Paul Feuerstadt, Glenn TillotsonAdvances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.Advances in Therapy|October 30, 2024
Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical TrialOlivier Bruyère, Jean-Yves ReginsterAdvances in Therapy|October 29, 2024
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 ComorbiditiesMark Boguniewicz, Lawrence D Sher, Amy S Paller, et al.Advances in Therapy|October 28, 2024
Safety and Tolerability of Nintedanib in Patients with Fibrosing Interstitial Lung Diseases: Post-marketing DataNazia Chaudhuri, Arata Azuma, Kamila Sroka-Saidi, et al.Advances in Therapy|September 6, 2024
Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate-Severe Asthma: A Clinical Modelling and Simulation StudyPierluigi Paggiaro, Gabriel Garcia, Nicolas Roche, et al.Advances in Therapy|September 6, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database StudyUma Borate, Karen Seiter, Ravi Potluri, et al.Advances in Therapy|September 11, 2024
Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi ArabiaMohammed Alluhidan, Abdulrahman Alturaiki, Hana Alabdulkarim, et al.Advances in Therapy|September 9, 2024
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)Eric Simpson, Pablo Fernández-Peñas, Marjolein de Bruin-Weller, et al.Pageof 450